orchestrabiomed.com (OBIO): Kapitalisasi marang pendapatan
Orchestra BioMed (OBIO) maintains a pristine image due to its alliances with medtech leaders to drive innovation. The business focuses on developing bioelectronic systems for the treatment of hypertension and cardiology. Currently, the company is deploying capital toward clinical trials and remains unprofitable. The price/sales ratio reflects the market valuation relative to revenue, with the current value standing at 12.20.
Rincian analitis perusahaan Orchestra BioMed (OBIO)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal Orchestra BioMed|OBIO - Utang jangka dawa marang modal|Rasio utang jangka cendhak marang ekuitas orchestrabiomed.com|OBIO - Gunggung utang perusahaan|Utang-utang marang kapitalisasi buku Orchestra BioMed|OBIO - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Orchestra BioMed|Rasio jangkoan perantara orchestrabiomed.com
- data bathi lan kelipatan valuasi:
OBIO - Bathi resik|Bathi resik sing dikarepake Orchestra BioMed|OBIO - Rasio rega marang bathi|Pangali forward rega marang bathi Orchestra BioMed Inc.|OBIO - Pangali rega marang bathi tumrap wutah|Pangali EV/EBITDA Orchestra BioMed|OBIO - Bathi operasional EBITDA|Bathi resik saben saham sajrone patang kuartal pungkasan Orchestra BioMed|OBIO - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan orchestrabiomed.com|OBIO - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Orchestra BioMed
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:OBIO Orchestra BioMed Inc.
The selection of defensive assets is based on identifying undervalued companies with stable capital, which for Orchestra BioMed (OBIO) is confirmed by its status as a trusted partner for global medtech leaders in bringing innovations to market. An analysis of the historical P/S trend allows for the correlation of the business's market value with its actual revenue, determining the asset's degree of overheating and identifying the margin of safety through the ratio of market capitalization to sales volumes.
Pesaing Orchestra BioMed
BSX (bostonscientific.com) - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Edwards Lifesciences Corporation EW|RMD - Kapitalisasi marang pendapatan|OmniPod - Multiplikator P/S|Rega marang dodolan Zimmer Biomet Holdings|COO: Multiplikator P/S|Rasio kapitalisasi marang pendapatan ALGN|GMED (Globus Medical) - Multiplikator P/S|TransMedics Group Inc (TMDX) - Koefisien rega marang pendapatan|Multiplikator P/S ATEC|Kapitalisasi marang pendapatan Artivion Corp AORT|Multiplikator P/S ENOV (Enovis Corporation)|Multiplikator P/S integralife.com IART|ESTA - Rasio rega marang pendapatan|BBNX: Rasio rega marang pendapatan|IRMD (Iradimed) - Kapitalisasi marang pendapatan|Embecta Health - Rasio kapitalisasi pasar marang pendapatan|TNDM (Tandem Diabetes Care) - Multiplikator P/S|Rega marang dodolan axogeninc.com AXGN|Rasio rega marang pendapatan SI-BONE (SIBN)|Orthofix Medical (OFIX) - Multiplikator rega marang pendapatan|Bioventus Corp - Kapitalisasi marang pendapatan|Multiplikator P/S OrthoPediatrics Corp KIDS|Treace Medical Concepts - Multiplikator P/S|Koefisien rega marang pendapatan blade.com SRTA|Carlsmed (CARL) - Rasio rega marang pendapatan|Rasio rega marang dodolan RXST (RxSight Inc)|Rasio rega marang pendapatan ClearPoint Neuro Inc.|Kapitalisasi marang pendapatan Stereotaxis Corporation (STXS)|Multiplikator P/S STIM|SGHT - Rega marang dodolan|Rasio rega marang pendapatan Anika Therapeutics, Inc. ANIK|NSPR: Rasio kapitalisasi marang pendapatan|ZJYL: Kapitalisasi marang pendapatan|Vivani Medical, Inc. - Kapitalisasi marang volume dodolan|xtantmedical.com (XTNT) - Rasio rega marang pendapatan|Rega marang dodolan n1mtc.com (NMTC)|Rasio rega marang pendapatan Modular Medical Inc|MYO: Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S COCH|Kapitalisasi marang pendapatan Vivos Therapeutics Inc VVOS|Multiplikator P/S NVNO (enVVeno Medical)|Rasio kapitalisasi pasar marang pendapatan SINT|Tenon Medical - Multiplikator P/S|Rega marang dodolan ReWalk Robotics|autonomix.com (AMIX) - Rasio rega marang pendapatan|IVF - Koefisien rega marang pendapatan|Kapitalisasi marang pendapatan BBLG|AXNX (axonics.com) - Kapitalisasi marang volume dodolan|Rasio rega marang pendapatan BIOLASE (BIOL)|DYNT (dynatronics.com) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S FNA (Paragon 28)|Multiplikator P/S INVO Bioscience Inc. INVO
